Davis Street Building Room 142 B
B.Pharm, Devi Ahilya Vishwavidyalaya
Ph.D., University of Toledo
Dr. Rao received his Bachelor of Pharmacy degree from the DAVV University, Indore, India. For his Ph.D. degree (2006-2011), Dr. Rao joined the Department of Medicinal & Biological Chemistry at the University of Toledo, Ohio. Subsequently, Dr. Rao was a postdoctoral fellow (PDF) in the Department of Pharmacology and Experimental Therapeutics, in Dr. Youssef Sari's lab, at the University of Toledo. His work at the University of Toledo involved the synthesis and in vitro characterization of muscarinic antagonists (graduate research work) and the evaluation of in vivo efficacy of beta-lactams in alcohol-preferring P rats (postdoctoral work). Dr. Rao's research work at Toledo resulted in the successful publication of nine research articles and two review articles.
To continue his postdoctoral training and to better understand the interactions between HIV-1 infection and drug addiction, Dr. Rao joined Dr. Santosh Kumar's research group at the University of Missouri-Kansas City in March 2014.
After joining Dr. Kumar's lab, Dr. Rao was actively involved in studying drug-drug interactions between antiretroviral therapy (ART) and drugs of abuse. As a PDF in Dr. Kumar's lab, he successfully conducted experiments demonstrating the deleterious effects of ethanol and cigarette smoke condensate on HIV replication and the cellular pathways governing these effects. Dr. Rao collaborated with Dr. Kumar towards publishing novel data and reviewing the existing literature on drug-drug interactions between antiretroviral therapy and drug addiction. These efforts have resulted in the publication of four research articles, six review papers, and one book chapter.
In January 2016, Dr. Rao joined the College of Pharmacy at The University of Findlay as an Assistant Professor. Dr. Rao's current research interests include:
a) Examining the scope of drug-drug interactions between HIV medications and drugs of abuse
b) Studying the effects of drug abuse on HIV replication
c) Assessing the potential anti-cancer properties of novel compounds